Double-Blind Placebo Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria

BACKGROUND: Management of antihistamine refractory CIU has poorly defined therapeutic options. OBJECTIVE: To evaluate the efficacy of dapsone in antihistamine refractory CIU compared to placebo. METHODS: Twenty-two patients with antihistamine refractory CIU were randomly assigned to 100 mg of dapson...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Morgan, Matt, Cooke, Andrew, Rogers, Laura, Adams-Huet, Beverley, Khan, David A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165520/
https://ncbi.nlm.nih.gov/pubmed/25213055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2014.06.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia